Your browser doesn't support javascript.
loading
Levofloxacin Pharmacokinetics/Pharmacodynamics, Dosing, Susceptibility Breakpoints, and Artificial Intelligence in the Treatment of Multidrug-resistant Tuberculosis.
Deshpande, Devyani; Pasipanodya, Jotam G; Mpagama, Stellah G; Bendet, Paula; Srivastava, Shashikant; Koeuth, Thearith; Lee, Pooi S; Bhavnani, Sujata M; Ambrose, Paul G; Thwaites, Guy; Heysell, Scott K; Gumbo, Tawanda.
Afiliação
  • Deshpande D; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Pasipanodya JG; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Mpagama SG; Kibong'oto Infectious Diseases Hospital, Sanya Juu, Tanzania.
  • Bendet P; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Srivastava S; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Koeuth T; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Lee PS; Center for Infectious Diseases Research and Experimental Therapeutics, Baylor Research Institute, Baylor University Medical Center, Dallas, Texas.
  • Bhavnani SM; Institute for Clinical Pharmacodynamics, Schenectady, New York.
  • Ambrose PG; Institute for Clinical Pharmacodynamics, Schenectady, New York.
  • Thwaites G; Nuffield Department of Medicine, Centre for Tropical Medicine and Global Health, Churchill Hospital, Oxford, United Kingdom.
  • Heysell SK; Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam.
  • Gumbo T; Division of Infectious Diseases and International Health, University of Virginia, Charlottesville.
Clin Infect Dis ; 67(suppl_3): S293-S302, 2018 11 28.
Article em En | MEDLINE | ID: mdl-30496461
Assuntos
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Inteligência Artificial / Tuberculose Resistente a Múltiplos Medicamentos / Levofloxacino / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article
Texto completo
Adicionar na Minha BVS
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Bases de dados: MEDLINE Assunto principal: Tuberculose Pulmonar / Inteligência Artificial / Tuberculose Resistente a Múltiplos Medicamentos / Levofloxacino / Mycobacterium tuberculosis / Antituberculosos Tipo de estudo: Health_economic_evaluation / Prognostic_studies Limite: Humans Idioma: En Revista: Clin Infect Dis Assunto da revista: DOENCAS TRANSMISSIVEIS Ano de publicação: 2018 Tipo de documento: Article